nisoxetine has been researched along with MPTP Neurotoxicity Syndrome in 1 studies
nisoxetine: potent inhibitor for norepinephrine uptake into rat brain synaptosomes & brain; NM refers to (+-)-isomer; RN given refers to parent cpd; structure
nisoxetine : A secondary amino compound that is N-methyl-3-phenylpropan-1-amine substituted at position 3 by a 2-methoxyphenoxy group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rommelfanger, KS | 1 |
| Weinshenker, D | 1 |
| Miller, GW | 1 |
1 other study available for nisoxetine and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
Reduced MPTP toxicity in noradrenaline transporter knockout mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Blotting, Western; Brain Chemistry; C | 2004 |